Found 38 articles for: "Carcinoma"
Efficacy and Safety of Cosibelimab for Advanced Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel
May 2026 | Volume 25 | Issue 5 | Original Article | 413 | Copyright © May 2026
Background: Cutaneous squamous cell carcinoma (cSCC) represents a significant clinical challenge in patients with locally advanced (laCSCC) or metastatic (mCSCC) disease who are ...
Read MoreSafety and Efficacy of Aminolevulinic Acid 20% Topical Solution Activated by Blue Light for Facial Cutaneous Squamous Cell Carcinoma in situ
May 2026 | Volume 25 | Issue 5 | Original Article | 454 | Copyright © May 2026
Background: Squamous cell carcinoma in situ (isSCC) is an early-stage cutaneous malignancy that requires effective treatment to prevent progression to invasive SCC. Aminolevulini...
Read MoreEfficacy and Safety of Topical Metformin vs Kligman Formula in the Treatment of Melasma: A Split-Face Study
May 2026 | Volume 25 | Issue 5 | Original Article | 435 | Copyright © May 2026
Background: Melasma is an acquired pigmentary disorder characterized by symmetrical hyperpigmented macules and patches on sun-exposed areas, primarily the face. Kligman's formula...
Read MoreThe Emerging Role of Metformin in Skin Cancer: Mechanistic and Clinical Insights
May 2026 | Volume 25 | Issue 5 | Original Article | 444 | Copyright © May 2026
Background: Metformin, widely used for type 2 diabetes mellitus, has demonstrated antitumor effects through modulation of metabolic and immune pathways. This review explores its ...
Read MoreMalignancy Risk in Autoimmune Blistering Disorders: A Retrospective Cohort Study
May 2026 | Volume 25 | Issue 5 | Editorials | e47 | Copyright © May 2026
Increased Odds of Multiple Primary Cancers in Merkel Cell Carcinoma Patients: A Large-Scale Propensity-Matched Analysis
August 2025 | Volume 24 | Issue 8 | Editorials | e51 | Copyright © August 2025
Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey
July 2025 | Volume 24 | Issue 7 | Features | 722 | Copyright © July 2025
Recent studies have demonstrated functional and cosmetic benefits with the use of hedgehog pathway inhibitors in the neoadjuvant setting for basal cell carcinoma (BCC). This study investigated th...
Read MoreClinical Features and the Management of Drug-Induced Eruptive Keratoacanthoma and Squamous Cell Carcinoma: A Review of 172 Cases
May 2025 | Volume 24 | Issue 5 | Original Article | 476 | Copyright © May 2025
Background: The sudden appearance of keratoacanthomas (KA) and squamous cell carcinomas (SCC) is a serious complication of several oncologic and immunomodulatory medications. The...
Read MoreEfficacy and Safety of Hedgehog Inhibitors for Advanced Basal Cell Carcinoma: An Expert Consensus Panel
May 2025 | Volume 24 | Issue 5 | Original Article | 465 | Copyright © May 2025
Background: Hedgehog inhibitors (HHIs) can be used to treat patients with locally advanced basal cell carcinoma (laBCC) who are not candidates for surgery or radiation or whose t...
Read MoreMedical and Surgical Management of Multifocal Superficial Basal Cell Carcinoma
May 2025 | Volume 24 | Issue 5 | Original Article | 483 | Copyright © May 2025
Background: Multifocal superficial basal cell carcinoma (sBCC) is a subtype of BCC characterized by subclinical extension of noncontiguous tumor islands and high recurrence rates...
Read MoreSquamous Cell Carcinoma In Situ on High-Risk Sites and With Larger Sizes Require More Stages for Clearance With Mohs Surgery
May 2025 | Volume 24 | Issue 5 | Original Article | 494 | Copyright © May 2025
Background: Few studies have evaluated Mohs micrographic surgery (MMS) for the treatment of squamous cell carcinoma in situ or evaluated the results by Mohs Appropriate Use Crite...
Read MoreEndocrine Mucin Producing Sweat Gland Carcinoma Treated With Mohs Micrographic Surgery: A Systematic Review
May 2025 | Volume 24 | Issue 5 | Original Article | 498 | Copyright © May 2025
Background: Endocrine Mucin Producing Sweat Gland Carcinoma (EMPSGC) is a low-grade, cutaneous adnexal neoplasm. It is believed to have a potential for local recurrence as well a...
Read MoreSynergistic Mechanisms of 5-Fluorouracil and Imiquimod in the Treatment of Actinic Keratoses
May 2025 | Volume 24 | Issue 5 | Editorials | e35 | Copyright © May 2025
Citation: Regester RM, Cannella AC, Thiele GM, et al. Synergistic mechanisms of 5-fluorouracil and imiquimod in the treatment of actinic keratoses. J Drugs Dermatol. 2025;24(5):e35....
Read MoreSurgical Outcomes of Cylindrocarcinoma Treated With Mohs Micrographic Surgery and Excision: A Systematic Review
May 2025 | Volume 24 | Issue 5 | Original Article | 444 | Copyright © May 2025
Background: Cylindromas are benign adnexal tumors often associated with conditions such as Brooke-Spiegler Syndrome and familial cylindromatosis. Cylindromas can undergo malignan...
Read MoreNeoadjuvant Sonidegib for the Management of Locally Advanced Basal Cell Carcinoma: A Case Report
March 2025 | Volume 24 | Issue 3 | Case Reports | 329 | Copyright © March 2025
Neoadjuvant Hedgehog Pathway Inhibitor (HPI) therapy, utilizing sonidegib and vismodegib, has shown great potential in managing locally advanced basal cell carcinoma (laBCC). While effective, the...
Read MoreMultidisciplinary Approach to Treatment of Advanced Basal Cell Carcinoma With Involvement of the Left Orbit
June 2024 | Volume 23 | Issue 6 | Case Reports | e142 | Copyright © June 2024
Incorporating a Prognostic Gene Expression Profile Test into the Management of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel Report
February 2024 | Volume 23 | Issue 2 | Original Article | 54 | Copyright © February 2024
Background: Cutaneous squamous cell carcinoma (cSCC) is a growing health concern with a rapidly increasing incidence. Disease-specific mortality is typically preceded by a m...
Read MoreCryosurgery and 5-Fluorouracil Combination Therapy for Treatment of Bowen's Disease and Superficial Basal Cell Carcinoma
December 2023 | Volume 22 | Issue 12 | Original Article | 1166 | Copyright © December 2023
Background: Non-melanoma skin cancer (NMSC), which includes both Bowen's disease (BD) and superficial basal cell carcinoma (sBCC), is the most commonly diagnosed cancer in Canada...
Read MoreKeratinocyte Carcinoma Chemoprevention With a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin
May 2023 | Volume 22 | Issue 5 | Original Article | 486 | Copyright © May 2023
Background: The incidence of keratinocyte carcinomas (KCs), comprising basal and squamous cell carcinomas, is rising in the United States. Chemoprevention is one modality by whic...
Read MoreNon-Invasive Treatment of Basal Cell Carcinoma: Photodynamic Therapy Following Curettage
May 2023 | Volume 22 | Issue 5 | Original Article | 481 | Copyright © May 2023
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
